BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
204 results:

  • 1. TSPAN6 reinforces the malignant progression of glioblastoma via interacting with CDK5RAP3 and regulating stat3 signaling pathway.
    Zhang C; Du FH; Wang RX; Han WB; Lv X; Zeng LH; Chen GQ
    Int J Biol Sci; 2024; 20(7):2440-2453. PubMed ID: 38725860
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. KIAA0040 enhances glioma growth by controlling the JAK2/stat3 signalling pathway.
    He J; Xue K; Fan F; Li L; Rao X; Liu W; Nie C
    J Cell Mol Med; 2024 Apr; 28(8):e18332. PubMed ID: 38661644
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The FKBP51s Splice Isoform Predicts Unfavorable prognosis in Patients with Glioblastoma.
    Giordano C; Marrone L; Romano S; Della Pepa GM; Donzelli CM; Tufano M; Capasso M; Lasorsa VA; Quintavalle C; Guerri G; Martucci M; Auricchio A; Gessi M; Sala E; Olivi A; Romano MF; Gaudino S
    Cancer Res Commun; 2024 May; 4(5):1296-1306. PubMed ID: 38651817
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/stat3 axis.
    Qiu Y; Pei D; Wang M; Wang Q; Duan W; Wang L; Liu K; Guo Y; Luo L; Guo Z; Guan F; Wang Z; Xing A; Liu Z; Ma Z; Jiang G; Yan D; Liu X; Zhang Z; Wang W
    CNS Neurosci Ther; 2024 Apr; 30(4):e14709. PubMed ID: 38605477
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.
    Jin X; Zhu J; Yu H; Shi S; Shen K; Gu J; Yin Z; Yu Z; Wu J
    PLoS One; 2024; 19(3):e0298055. PubMed ID: 38530810
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. stat3 phosphorylation inhibitor Bt354 exhibits anti-neoplastic activity in glioblastoma multiforme cells.
    Chiang YC; Selvam P; Liu YX; Shih PC; Chen NF; Kuo HM; Lin HY; Wen ZH; Chen WF
    Environ Toxicol; 2024 Jun; 39(6):3292-3303. PubMed ID: 38415901
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
    Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
    Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating stat3 phosphorylation.
    Zhang J; Li R; Zhang H; Wang S; Zhao Y
    Carcinogenesis; 2024 Apr; 45(4):235-246. PubMed ID: 38142122
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery.
    Yue C; Lian W; Duan M; Xia D; Cao X; Peng J
    Environ Toxicol; 2024 Mar; 39(3):1858-1873. PubMed ID: 38140739
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. REC8 regulates neuroblastoma cell proliferation, migration, invasion, and angiogenesis via stat3/VEGF signaling.
    Wang Q; Fan W; Hao Z; Liang B; Fan M; Zhao Z; Li Z
    J Egypt Natl Canc Inst; 2023 Dec; 35(1):41. PubMed ID: 38105365
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating stat3 in glioblastoma.
    Chen Y; Mu Y; Guan Q; Li C; Zhang Y; Xu Y; Zhou C; Guo Y; Ma Y; Zhao M; Ji G; Liu P; Sun D; Sun H; Wu N; Jin Y
    Cell Death Dis; 2023 Nov; 14(11):757. PubMed ID: 37985768
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/stat3 signaling.
    Zhong Z; Zhong H
    Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CTSC promoted the migration and invasion of glioma cells via activation of stat3/SERPINA3 axis.
    Li Q; Wan C; Zhang Z; Liu G; Wang S
    Gene; 2024 Jan; 893():147948. PubMed ID: 37925117
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Multi-Omics Analyses Reveal Mitochondrial Dysfunction Contributing to Temozolomide Resistance in Glioblastoma cells.
    Zhang H; Chen Y; Liu X; Deng H
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759808
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.
    Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L
    Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. tumor-associated astrocytes promote tumor progression of Sonic Hedgehog medulloblastoma by secreting lipocalin-2.
    Li H; Liu Y; Liu Y; Xu L; Sun Z; Zheng D; Liu X; Song C; Zhang Y; Liang H; Yang B; Tian X; Luo J; Chang Q
    Brain Pathol; 2024 Jan; 34(1):e13212. PubMed ID: 37721122
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma.
    Pang L; Dunterman M; Guo S; Khan F; Liu Y; Taefi E; Bahrami A; Geula C; Hsu WH; Horbinski C; James CD; Chen P
    Nat Immunol; 2023 Oct; 24(10):1654-1670. PubMed ID: 37667051
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway.
    Zhao G; Deng Z; Li X; Wang H; Chen G; Feng M; Zhou Y
    Exp Brain Res; 2023 Oct; 241(10):2409-2418. PubMed ID: 37644332
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P
    Bergkamp ND; van Senten JR; Brink HJ; Bebelman MP; van den Bor J; Çobanoğlu TS; Dinkla K; Köster J; Klau G; Siderius M; Smit MJ
    Sci Signal; 2023 Aug; 16(798):eade6737. PubMed ID: 37582160
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ANXA1 Promotes tumor Immune Evasion by Binding PARP1 and Upregulating stat3-Induced Expression of PD-L1 in Multiple Cancers.
    Xiao D; Zeng T; Zhu W; Yu ZZ; Huang W; Yi H; Lu SS; Feng J; Feng XP; Wu D; Wen Q; Zhou JH; Yuan L; Zhuang W; Xiao ZQ
    Cancer Immunol Res; 2023 Oct; 11(10):1367-1383. PubMed ID: 37566399
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.